Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

Conditions:   Bariatric Surgery Candidate;   Bone Loss Interventions:   Drug: Denosumab;   Drug: Placebo Sponsors:   Massachusetts General Hospital;   University of California, San Francisco;   San Francisco VA Health Care System Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials